This month, the team was on-site in Seattle, Washington, for the 2022 American Academy of Neurology Annual Meeting, providing live coverage of sessions and presentations from the floor of the convention center. While there, the team conducted a variety of sit-down interviews with experts about hot button issues and topics at the annual meeting.
Among these included conversations about the associations between stroke and COVID-19 with Matthew Schindler, MD, PhD; SanBio’s investigational agent for traumatic brain injury with Peter J. McAllister, MD, FAAN; the details of an item-level analysis of aducanumab (Aduhelm; Biogen) with Sharon Cohen, MD, FRCPC; the paradigm shift in therapeutics for amyotrophic lateral sclerosis (ALS) with Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMS; the priorities for research in migraine with Rashmi B. Halker-Singh, MD, FAAN, and Paul Mathew, MD, DNBPAS, FAAN, FAHS; and the long-term neurological trajectories observed in severe COVID-19 cases with Jennifer Frontera, MD.
Click through the videos to see and read more from each expert’s exclusive conversation with NeurologyLive® from AAN 2022.
FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine
Tackling Neurodegeneration in Multiple Sclerosis: Emily Harrington, MD, PhD
Periconceptional Folic Acid Supplementation Decreases Risk of Preterm Birth in Epilepsy
Changing the Future of Stroke Care: The 2021 ASA/AHA Prevention Guidelines